SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-097718
Filing Date
2024-04-16
Accepted
2024-04-16 16:01:59
Documents
9
Effectiveness Date
2024-04-16

Document Format Files

Seq Description Document Type Size
1 S-3ASR d798591ds3asr.htm S-3ASR 304619
2 EX-4.10 d798591dex410.htm EX-4.10 365710
3 EX-4.11 d798591dex411.htm EX-4.11 369125
4 EX-5.1 d798591dex51.htm EX-5.1 36563
5 EX-23.1 d798591dex231.htm EX-23.1 1816
6 EX-FILING FEES d798591dexfilingfees.htm EX-FILING FEES 34841
7 GRAPHIC g798591g00a02.jpg GRAPHIC 51184
8 GRAPHIC g798591g0413113810482.jpg GRAPHIC 2320
9 GRAPHIC g798591g0413113812506.jpg GRAPHIC 1602
  Complete submission text file 0001193125-24-097718.txt   1186274
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-278726 | Film No.: 24847784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)